Fulgent Genetics Net Profit Margin 2015-2023 | FLGT
Fulgent Genetics net profit margin from 2015 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Fulgent Genetics Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2023-12-31 | $0.29B | $-0.17B | -57.59% |
| 2023-09-30 | $0.29B | $-0.06B | -21.95% |
| 2023-06-30 | $0.31B | $-0.05B | -15.58% |
| 2023-03-31 | $0.37B | $-0.03B | -6.85% |
| 2022-12-31 | $0.62B | $0.14B | 23.26% |
| 2022-09-30 | $0.80B | $0.27B | 33.87% |
| 2022-06-30 | $0.93B | $0.39B | 42.49% |
| 2022-03-31 | $0.95B | $0.46B | 48.32% |
| 2021-12-31 | $0.99B | $0.51B | 51.16% |
| 2021-09-30 | $1.04B | $0.57B | 55.02% |
| 2021-06-30 | $0.91B | $0.49B | 54.29% |
| 2021-03-31 | $0.77B | $0.42B | 53.95% |
| 2020-12-31 | $0.42B | $0.21B | 50.71% |
| 2020-09-30 | $0.14B | $0.05B | 35.56% |
| 2020-06-30 | $0.04B | $0.00B | 4.65% |
| 2020-03-31 | $0.03B | $-0.00B | -2.94% |
| 2019-12-31 | $0.03B | $-0.00B | -3.23% |
| 2019-09-30 | $0.03B | $-0.00B | -10.34% |
| 2019-06-30 | $0.03B | $-0.01B | -20.00% |
| 2019-03-31 | $0.02B | $-0.01B | -27.27% |
| 2018-12-31 | $0.02B | $-0.01B | -27.27% |
| 2018-09-30 | $0.02B | $-0.01B | -30.00% |
| 2018-06-30 | $0.02B | $-0.01B | -31.58% |
| 2018-03-31 | $0.02B | $-0.01B | -26.32% |
| 2017-12-31 | $0.02B | $-0.00B | -15.79% |
| 2017-09-30 | $0.02B | 0 | 0.00% |
| 2017-06-30 | $0.02B | 0 | 0.00% |
| 2017-03-31 | $0.02B | $-0.01B | -25.00% |
| 2016-12-31 | $0.02B | $-0.01B | -33.33% |
| 2016-06-30 | $0.01B | $-0.01B | -60.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.619B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $35.723B | 19.61 |
| Inspire Medical Systems (INSP) | United States | $7.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.477B | 0.00 |
| Axonics (AXNX) | United States | $3.412B | 0.00 |
| 10x Genomics (TXG) | United States | $3.208B | 0.00 |
| Enovis (ENOV) | United States | $3.038B | 23.08 |
| Azenta (AZTA) | United States | $2.905B | 236.82 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.820B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.680B | 0.00 |
| Privia Health (PRVA) | United States | $2.139B | 94.89 |
| Schrodinger (SDGR) | United States | $1.827B | 0.00 |
| Omnicell (OMCL) | United States | $1.248B | 30.53 |
| Phreesia (PHR) | United States | $1.185B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.821B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.680B | 0.00 |
| Talkspace (TALK) | United States | $0.536B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.373B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.329B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.318B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.183B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.164B | 0.00 |
| American Well (AMWL) | United States | $0.154B | 0.00 |
| Outset Medical (OM) | United States | $0.147B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.129B | 0.00 |
| Augmedix (AUGX) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.04 |
| 111 (YI) | China | $0.088B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.048B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |